Insider trades

Mark Schoenberg, Chief Officer of UroGen Pharma URGN, has filed 0 purchases and 26 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/22.

Mark Schoenberg

Chief Medical Officer
First filing
23/02/02
Trades
70 trades
Buys / sales
0 / 26
12-month net buying
−$1.2M
Last trade
06/22

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/2206/2410,000 sh$35.01$350,100−7.2%
Open-market sale06/0806/095,222 sh$27.30$142,560.6−3.6%
Open-market sale10b5-1 plan05/0805/1110,000 sh$30.00$300,000−6.9%
URGN
Open-market sale02/0302/047,373 sh3 trades$19.69avg.$145,174.37−4.8%
Open-market sale10b5-1 plan25/11/1925/11/2010,000 sh$25.00$250,000−6.7%
Open-market sale25/09/0825/09/09871 sh$19.11$16,644.81−0.6%
Open-market sale25/08/1125/08/1310,000 sh$17.69$176,900−6.3%
Open-market sale25/07/2825/07/305,149 sh$19.14$98,551.86−3.2%
Open-market sale25/06/0925/06/115,162 sh$7.37$38,043.94−3.3%
URGN
Open-market sale25/01/3125/02/044,551 sh3 trades$11.14avg.$50,698.14−3.0%
Open-market sale24/09/0924/09/12859 sh$13.08$11,235.72−0.6%
Open-market sale24/06/1024/06/115,153 sh$13.08$67,401.24−3.4%
Open-market sale24/03/1824/03/2012,000 sh$14.05$168,600−7.9%
URGN
Open-market saleAmendment24/02/0124/02/053,789 sh3 trades$15.78avg.$59,790.42−2.4%
URGN
Open-market sale24/01/3124/02/023,789 sh3 trades$15.74avg.$59,638.86−2.4%
URGN
Open-market sale23/01/3123/02/021,900 sh3 trades$10.12avg.$19,228−1.3%